Reaction Details  Report a problem with these data
Target
Integrin alpha-V/beta-5
Ligand
BDBM50399919
Substrate
n/a
Meas. Tech.
ChEMBL_877702 (CHEMBL2185913)
IC50
76±n/a nM
Citation
 Colombo, R; Mingozzi, M; Belvisi, L; Arosio, D; Piarulli, U; Carenini, N; Perego, P; Zaffaroni, N; De Cesare, M; Castiglioni, V; Scanziani, E; Gennari, C Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrinaVß3. J Med Chem 55:10460-74 (2012) [PubMed]  Article
Target
Name:
Integrin alpha-V/beta-5
Synonyms:
ITGAV/ITGB5 | Integrin beta-5/Vitronectin receptor alpha
Type:
Enzyme
Mol. Mass.:
n/a
Description:
n/a
Components:
This complex has 2 components.
Component 1
Name:
Integrin alpha-V
Synonyms:
ITAV_HUMAN | ITGAV | Integrin alpha-V/alpha-5 | MSK8 | VNRA | VTNR | Vitronectin receptor | Vitronectin receptor subunit alpha
Type:
PROTEIN
Mol. Mass.:
116024.92
Organism:
Homo sapiens (Human)
Description:
ChEMBL_582336
Residue:
1048
Sequence:
MAFPPRRRLRLGPRGLPLLLSGLLLPLCRAFNLDVDSPAEYSGPEGSYFGFAVDFFVPSASSRMFLLVGAPKANTTQPGIVEGGQVLKCDWSSTRRCQPIEFDATGNRDYAKDDPLEFKSHQWFGASVRSKQDKILACAPLYHWRTEMKQEREPVGTCFLQDGTKTVEYAPCRSQDIDADGQGFCQGGFSIDFTKADRVLLGGPGSFYWQGQLISDQVAEIVSKYDPNVYSIKYNNQLATRTAQAIFDDSYLGYSVAVGDFNGDGIDDFVSGVPRAARTLGMVYIYDGKNMSSLYNFTGEQMAAYFGFSVAATDINGDDYADVFIGAPLFMDRGSDGKLQEVGQVSVSLQRASGDFQTTKLNGFEVFARFGSAIAPLGDLDQDGFNDIAIAAPYGGEDKKGIVYIFNGRSTGLNAVPSQILEGQWAARSMPPSFGYSMKGATDIDKNGYPDLIVGAFGVDRAILYRARPVITVNAGLEVYPSILNQDNKTCSLPGTALKVSCFNVRFCLKADGKGVLPRKLNFQVELLLDKLKQKGAIRRALFLYSRSPSHSKNMTISRGGLMQCEELIAYLRDESEFRDKLTPITIFMEYRLDYRTAADTTGLQPILNQFTPANISRQAHILLDCGEDNVCKPKLEVSVDSDQKKIYIGDDNPLTLIVKAQNQGEGAYEAELIVSIPLQADFIGVVRNNEALARLSCAFKTENQTRQVVCDLGNPMKAGTQLLAGLRFSVHQQSEMDTSVKFDLQIQSSNLFDKVSPVVSHKVDLAVLAAVEIRGVSSPDHVFLPIPNWEHKENPETEEDVGPVVQHIYELRNNGPSSFSKAMLHLQWPYKYNNNTLLYILHYDIDGPMNCTSDMEINPLRIKISSLQTTEKNDTVAGQGERDHLITKRDLALSEGDIHTLGCGVAQCLKIVCQVGRLDRGKSAILYVKSLLWTETFMNKENQNHSYSLKSSASFNVIEFPYKNLPIEDITNSTLVTTNVTWGIQPAPMPVPVWVIILAVLAGLLLLAVLVFVMYRMGFFKRVRPPQEEQEREQLQPHENGEGNSET
  
Component 2
Name:
Integrin beta-5
Synonyms:
ITB5_HUMAN | ITGB5
Type:
PROTEIN
Mol. Mass.:
88047.37
Organism:
Homo sapiens (Human)
Description:
EBI_10915
Residue:
799
Sequence:
MPRAPAPLYACLLGLCALLPRLAGLNICTSGSATSCEECLLIHPKCAWCSKEDFGSPRSITSRCDLRANLVKNGCGGEIESPASSFHVLRSLPLSSKGSGSAGWDVIQMTPQEIAVNLRPGDKTTFQLQVRQVEDYPVDLYYLMDLSLSMKDDLDNIRSLGTKLAEEMRKLTSNFRLGFGSFVDKDISPFSYTAPRYQTNPCIGYKLFPNCVPSFGFRHLLPLTDRVDSFNEEVRKQRVSRNRDAPEGGFDAVLQAAVCKEKIGWRKDALHLLVFTTDDVPHIALDGKLGGLVQPHDGQCHLNEANEYTASNQMDYPSLALLGEKLAENNINLIFAVTKNHYMLYKNFTALIPGTTVEILDGDSKNIIQLIINAYNSIRSKVELSVWDQPEDLNLFFTATCQDGVSYPGQRKCEGLKIGDTASFEVSLEARSCPSRHTEHVFALRPVGFRDSLEVGVTYNCTCGCSVGLEPNSARCNGSGTYVCGLCECSPGYLGTRCECQDGENQSVYQNLCREAEGKPLCSGRGDCSCNQCSCFESEFGKIYGPFCECDNFSCARNKGVLCSGHGECHCGECKCHAGYIGDNCNCSTDISTCRGRDGQICSERGHCLCGQCQCTEPGAFGEMCEKCPTCPDACSTKRDCVECLLLHSGKPDNQTCHSLCRDEVITWVDTIVKDDQEAVLCFYKTAKDCVMMFTYVELPSGKSNLTVLREPECGNTPNAMTILLAVVGSILLVGLALLAIWKLLVTIHDRREFAKFQSERSRARYEMASNPLYRKPISTHTVDFTFNKFNKSYNGTVD
  
Inhibitor
Name:
BDBM50399919
Synonyms:
CHEMBL2180983
Type:
Small organic molecule
Emp. Form.:
C78H91N11O24
Mol. Mass.:
1566.6164
SMILES:
CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](OC(=O)CCC(=O)NCc1ccc(CN2[C@H]3CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)NC[C@@H](NC3=O)C2=O)cc1)[C@@H](NC(=O)c1ccccc1)c1ccccc1 |r,wU:65.70,80.85,22.23,26.26,4.3,10.10,30.33,28.30,60.64,wD:97.105,12.12,8.45,23.37,44.49,89.94,c:5,(3.53,-26.48,;3.49,-24.94,;2.14,-24.21,;4.81,-24.14,;6.16,-24.86,;6.22,-27.9,;6.24,-29.43,;4.92,-30.22,;7.59,-30.2,;8.91,-29.4,;8.88,-27.87,;10.23,-28.61,;10.21,-27.08,;11.56,-27.82,;11.57,-29.38,;10.26,-30.14,;12.91,-30.11,;14.22,-29.31,;15.57,-30.05,;15.6,-31.61,;14.28,-32.4,;12.94,-31.65,;10.17,-25.54,;11.49,-24.75,;13.04,-24.72,;13.01,-23.19,;11.46,-23.19,;10.11,-22.45,;8.78,-23.26,;8.73,-21.72,;8.82,-24.8,;9.24,-26.26,;7.47,-24.06,;7.43,-22.52,;11.9,-26.23,;13.25,-26.97,;14.58,-26.18,;13.27,-28.52,;7.54,-27.11,;6.72,-25.81,;8.29,-25.76,;7.6,-31.72,;6.28,-32.51,;4.95,-31.76,;6.3,-34.04,;7.64,-34.8,;8.97,-34.03,;8.96,-32.49,;10.31,-34.79,;11.64,-34.01,;12.98,-34.77,;12.99,-36.31,;14.31,-33.99,;15.65,-34.75,;16.97,-33.97,;18.31,-34.74,;19.64,-33.97,;19.63,-32.42,;20.96,-31.64,;22.3,-32.4,;23.61,-31.62,;23.6,-30.08,;24.92,-29.29,;24.9,-27.75,;26.27,-30.04,;27.59,-29.25,;27.57,-27.71,;26.22,-26.96,;26.2,-25.42,;24.86,-24.67,;24.83,-23.13,;23.49,-22.38,;26.15,-22.34,;28.94,-30,;30.26,-29.21,;28.96,-31.54,;30.3,-32.29,;30.33,-33.83,;31.67,-34.58,;29,-34.62,;29.03,-36.16,;30.37,-36.91,;30.4,-38.45,;29.07,-39.24,;31.74,-39.2,;27.71,-36.95,;27.73,-38.49,;25.04,-36.99,;23.64,-36.24,;23.63,-34.7,;24.96,-33.93,;24.95,-32.39,;26.29,-31.61,;22.3,-33.94,;20.97,-34.72,;18.28,-31.66,;16.96,-32.44,;4.97,-34.83,;3.63,-34.09,;2.32,-34.86,;2.34,-36.42,;.98,-34.13,;.96,-32.57,;-.39,-31.83,;-1.7,-32.63,;-1.69,-34.16,;-.35,-34.92,;5,-36.36,;6.35,-37.1,;6.37,-38.66,;5.04,-39.45,;3.7,-38.69,;3.68,-37.16,)|
Structure:
Search PDB for entries with ligand similarity: